Page 4 - Immunomodulatory Drugs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunomodulatory drugs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunomodulatory Drugs Today - Breaking & Trending Today

Immunis Chairman Dr. Hans Keirstead to Present at Innovative Therapies Days in France

IRVINE, Calif., October 09, 2023 Immunis, Inc., a private biotech pioneering cellular secretome treatments to address age and disease-related immune decline, is pleased to announce that its Chairman, Dr. Hans Keirstead, will be taking center stage at the prestigious Innovative Therapies Days conference in Besançon, France. Innovative Therapies Days is a premier event in medical innovation, showcasing presentations from esteemed clinicians, scientists, and industry partners. This year, the confe ....

Hans Keirstead , Immunis Inc , Innovative Therapies Days , Immuni Phase , Private Securities Litigation Reform Act , Innovative Therapies , Investigational Product , Clinical Trials , Scientific Discoveries ,

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not make a difference in outcomes for treating patients with an advanced form of thyroid cancer that develops from thyroid follicular cells called differentiated thyroid cancer (DTC). ....

United States , Megan Craig , Uchicago Medicine Comprehensive Cancer Center , University Of Chicago Medicine Comprehensive Cancer Center , Uchicago Medicine Comprehensive Cancer Center , Sari Rosenberg , Everett Vokes , Assistant Professor , Medicine Comprehensive Cancer , Thyroid Cancer , Clinical Trial , Growth Factor , Kinase Inhibitor ,